Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
Wave Life Sciences nearly tripled its share price on a week-on-week basis, as investors positioned their portfolios after the encouraging results of its obesity drug clinical trial, sparking rosy prospects for the company in a highly coveted industry. At intra-week trading, Wave Life Sciences Ltd. (NASDAQ:WVE) soared by as much as 190 percent to touch a new six-year high of $21.73 before trimming gains to finish the week just up by 121 percent. This followed stellar results from the first phase of its clinical trial to test the efficacy of WVE-007 on obese patients, where enrollees' body composition significantly improved. According to Wave Life Sciences Ltd. (NASDAQ:WVE), WVE-007, taken in just three months, resulted in a 4.5 percent total fat loss, 9.4 percent visceral fat reduction, and a 3.2 percent increase in lean mass. Notably, investors cheered the drug candidate's safety and tolerability results, having no recorded serious adverse reactions during the course of the t
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- WAVE Life Sciences (NASDAQ:WVE) was given a new $50.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=WVE&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street ZMarketBeat
- WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at B. Riley.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Wedbush.MarketBeat
- Wave Life Sciences: 200% Rally On 1% Weight Loss Feels Bloated [Seeking Alpha]Seeking Alpha
WVE
Earnings
- 11/10/25 - Miss
WVE
Sec Filings
- 12/11/25 - Form 424B5
- 12/11/25 - Form 8-K
- 12/10/25 - Form 4
- WVE's page on the SEC website